Results 51 to 60 of about 1,100,188 (302)

Risk evaluation for RoPax vessels [PDF]

open access: yes, 2008
The paper presents the results of a recent risk evalua-tion study for RoPax vessels, carried out as part of the activities of the SAFEDOR Integrated Project.
Konovessis, Dimitris, Vassalos, Dracos
core   +1 more source

Feasibility and Preliminary Efficacy of Integrative Neuromuscular Training for Childhood Cancer Survivors: A Pilot Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of childhood acute lymphoblastic leukemia (ALL) often exhibit early deficits in muscle and movement competence, which can compromise long‐term health. Integrative neuromuscular training (INT), a multifaceted approach combining fundamental movement activities with strength exercises, may help address these deficits during ...
Anna Maria Markarian   +7 more
wiley   +1 more source

COMPLIANCE TESTING OF IOWA’S SKID-MOUNTED SIGN DEVICE [PDF]

open access: yes, 1999
A wide variety of traffic control devices are used in work zones, some of which are nont ormally found on the roadside or in the traveled way outsideofthe work zones.
Faller, Ronald K.   +4 more
core   +1 more source

Assessing Cognitive Functioning in Children With Brain Tumors: Interaction of Neighborhood Social Determinants of Health and Neurological Risk

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background This study investigated how neighborhood‐level social determinants of health (SDOH), including redlining and neurological risk, interact to influence cognitive outcomes in children treated for brain tumors (CTBT). Methods A retrospective chart review of 161 CTBT aged 5–17 was conducted.
Alannah R. Srsich   +5 more
wiley   +1 more source

Multi-Criteria Analysis of Steel–Concrete–Steel Slab Performance: Dynamic Response Assessment Under Post-Fire Explosion

open access: yesBuildings
Steel–concrete–steel (SCS) composite slabs are widely used in critical infrastructures such as nuclear power plants, where systematic performance evaluation through multiple criteria is crucial due to their safety functions.
Shijie Zhang   +5 more
doaj   +1 more source

DEVELOPMENT OF A TL-3 F-SHAPE TEMPORARY CONCRETE MEDIAN BARRIER [PDF]

open access: yes, 1996
A temporary concrete median barrier (CMB) was designed and tested for compliance under the Test Level 3 (TL-3) guidelines specified in the Recommended Procedures for the Safety Performance Evaluation of Highway Features, National Cooperative Highway ...
Addink, Kenneth H.   +4 more
core   +1 more source

Radiation protection at CERN

open access: yes, 2013
This paper gives a brief overview of the general principles of radiation protection legislation; explains radiological quantities and units, including some basic facts about radioactivity and the biological effects of radiation; and gives an overview of ...
Forkel-Wirth, Doris   +6 more
core   +1 more source

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

Analysis of simulation results of damaged nuclear fuel accidents at NPPs with shell-type nuclear reactors

open access: yesTrudy Odesskogo Politehničeskogo Universiteta, 2015
Lessons from the accident at the Fukushima Daiichi NPP made it necessary to reevaluate and intensificate the work on modeling and analyzing various scenarios of severe accidents with damage to the nuclear fuel in the reactor, containment and spent ...
Igor L. Kozlov
doaj   +1 more source

Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study [PDF]

open access: yes, 2017
Objectives. To assess long-term efficacy, safety and tolerability of secukinumab up to 104 weeks in patients with active PsA. Methods. Patients with PsA (n = 397) were randomized to s.c. secukinumab 300, 150 or 75 mg or placebo at baseline, weeks 1, 2,
Delicha, Eumorphia-Maria   +9 more
core   +2 more sources

Home - About - Disclaimer - Privacy